{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T13:17:49Z","timestamp":1770815869606,"version":"3.50.1"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2019,5]]},"abstract":"<jats:sec>\n            <jats:title>Purpose<\/jats:title>\n            <jats:p>No study has analyzed a sizeable cohort that comprised solely peripheral T-cell lymphoma (PTCL) patients for the diagnostic and prognostic performance of <jats:sup>18<\/jats:sup>F-FDG PET\/CT for bone marrow (BM) involvement. This study aimed to investigate the utility of PET\/CT for the identification of BM involvement and to explore its prognostic relevance in patients with PTCL.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Eighty-three consecutive patients with newly diagnosed PTCL were enrolled in this retrospective study. The diagnosis of BM involvement was confirmed on the basis of positive BM histology or disappearance of marrow abnormalities on follow-up PET\/CT concurrently with a successful treatment response.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Of 28 patients with confirmed BM involvement, BM biopsy (BMB) and PET\/CT detected an involvement in 17 and 25 patients. Among 66 patients with negative BM histology, 11 patients had BM involvement detected by PET\/CT and furthermore showed significantly shorter progression-free and overall survival than patients without BM involvement. We recategorized the International Prognostic Index (IPI) risk groups based on the presence of BM involvement using the combined assessment of iliac crest marrow biopsy histology and PET\/CT (PET\/BMB-based IPI). PET\/BMB-based IPI tended to perform better than conventional BMB-based IPI.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>This study included the largest population of PTCL patients for PET\/CT evaluation of BM involvement so far. PET\/CT exhibited a higher sensitivity for BM involvement than BMB. Furthermore, BM assessment using PET\/CT identified patients at high risk of disease progression and mortality among those with negative BM histology, suggesting that PET\/CT may have a potential to improve existing prognostic strategies in PTCL.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/rlu.0000000000002516","type":"journal-article","created":{"date-parts":[[2019,3,25]],"date-time":"2019-03-25T21:29:20Z","timestamp":1553549360000},"page":"e336-e341","source":"Crossref","is-referenced-by-count":22,"title":["Diagnostic and Prognostic Value of Using 18F-FDG PET\/CT for the Evaluation of Bone Marrow Involvement in Peripheral T-Cell Lymphoma"],"prefix":"10.1097","volume":"44","author":[{"given":"Yoshiaki","family":"Abe","sequence":"first","affiliation":[{"name":"Division of Hematology\/Oncology, Department of Internal Medicine, Kameda Medical Center, Chiba;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiro","family":"Kitadate","sequence":"additional","affiliation":[{"name":"Division of Hematology\/Oncology, Department of Internal Medicine, Kameda Medical Center, Chiba;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiaki","family":"Usui","sequence":"additional","affiliation":[{"name":"Division of Cancer Information and Control, Department of Preventive Medicine, Aichi Cancer Center Research Institute, Nagoya; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kentaro","family":"Narita","sequence":"additional","affiliation":[{"name":"Division of Hematology\/Oncology, Department of Internal Medicine, Kameda Medical Center, Chiba;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Division of Hematology\/Oncology, Department of Internal Medicine, Kameda Medical Center, Chiba;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Miura","sequence":"additional","affiliation":[{"name":"Division of Hematology\/Oncology, Department of Internal Medicine, Kameda Medical Center, Chiba;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masami","family":"Takeuchi","sequence":"additional","affiliation":[{"name":"Division of Hematology\/Oncology, Department of Internal Medicine, Kameda Medical Center, Chiba;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eri","family":"O'uchi","sequence":"additional","affiliation":[{"name":"Department of Radiology, Kameda Medical Center, Chiba, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshihiro","family":"O'uchi","sequence":"additional","affiliation":[{"name":"Department of Radiology, Kameda Medical Center, Chiba, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kosei","family":"Matsue","sequence":"additional","affiliation":[{"name":"Division of Hematology\/Oncology, Department of Internal Medicine, Kameda Medical Center, Chiba;"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"bib2-20230925","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1200\/JCO.1997.15.6.2296","article-title":"Predictive capacity of the International Prognostic Factor Index in patients with peripheral T-cell lymphoma","volume":"15","year":"1997","journal-title":"J Clin Oncol"},{"key":"bib3-20230925","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/PAS.0b013e31826731b5","article-title":"Extranodal NK\/T-cell lymphoma, nasal type: a report of 73 cases at MD Anderson Cancer Center","volume":"37","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"bib4-20230925","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJM199309303291402","article-title":"A predictive model for aggressive non-Hodgkin's lymphoma","volume":"329","year":"1993","journal-title":"N Engl J Med"},{"key":"bib5-20230925","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1200\/JCO.2009.26.2493","article-title":"Standard International prognostic index remains a valid predictor of outcome for patients with aggressive CD20+ B-cell lymphoma in the rituximab era","volume":"28","year":"2010","journal-title":"J Clin Oncol"},{"key":"bib6-20230925","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1365-2141.2006.06124.x","article-title":"Prospective analysis of treatment outcome and prognostic factors in patients with T-cell lymphomas treated by CEOP-B: single institutional study","volume":"134","year":"2006","journal-title":"Br J Haematol"},{"key":"bib7-20230925","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/hon.853","article-title":"Clinico-pathologic features and outcome of Japanese patients with peripheral T-cell lymphomas","volume":"26","year":"2008","journal-title":"Hematol Oncol"},{"key":"bib8-20230925","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s00277-014-2188-8","article-title":"Analysis of prognostic factors and comparison of prognostic scores in peripheral T cell lymphoma, not otherwise specified: a single-institution study of 105 Chinese patients","volume":"94","year":"2015","journal-title":"Ann Hematol"},{"key":"bib9-20230925","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1182\/blood-2016-08-692566","article-title":"Peripheral T-cell lymphoma, not otherwise specified","volume":"129","year":"2017","journal-title":"Blood"},{"key":"bib10-20230925","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1182\/blood-2016-09-692541","article-title":"Angioimmunoblastic T-cell lymphoma: the many-faced lymphoma","volume":"129","year":"2017","journal-title":"Blood"},{"key":"bib11-20230925","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1200\/JCO.2013.54.8800","article-title":"Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification","volume":"32","year":"2014","journal-title":"J Clin Oncol"},{"key":"bib12-20230925","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.1200\/JCO.2013.53.5229","article-title":"Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group","volume":"32","year":"2014","journal-title":"J Clin Oncol"},{"key":"bib13-20230925","doi-asserted-by":"crossref","first-page":"e428","DOI":"10.1097\/RLU.0000000000002315","article-title":"Predictive value of FDG PET\/CT versus bone marrow biopsy in pediatric lymphoma","volume":"43","year":"2018","journal-title":"Clin Nucl Med"},{"key":"bib14-20230925","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1007\/s00259-009-1377-5","article-title":"(18)F-FDG PET\/CT bone\/bone marrow findings in Hodgkin's lymphoma may circumvent the use of bone marrow trephine biopsy at diagnosis staging","volume":"37","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib15-20230925","doi-asserted-by":"crossref","first-page":"4508","DOI":"10.1200\/JCO.2012.42.4036","article-title":"Routine bone marrow biopsy has little or no therapeutic consequence for positron emission tomography\/computed tomography\u2013staged treatment-naive patients with Hodgkin lymphoma","volume":"30","year":"2012","journal-title":"J Clin Oncol"},{"key":"bib16-20230925","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1007\/s00259-017-3647-y","article-title":"18F-FDG PET-CT imaging versus bone marrow biopsy in pediatric Hodgkin's lymphoma: a quantitative assessment of marrow uptake and novel insights into clinical implications of marrow involvement","volume":"44","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib17-20230925","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1093\/annonc\/mdy250","article-title":"Value of bone marrow biopsy in Hodgkin lymphoma patients staged by FDG PET: results from the German Hodgkin Study Group trials HD16, HD17, and HD18","volume":"29","year":"2018","journal-title":"Ann Oncol"},{"key":"bib18-20230925","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.2967\/jnumed.112.114710","article-title":"In newly diagnosed diffuse large B-cell lymphoma, determination of bone marrow involvement with 18F-FDG PET\/CT provides better diagnostic performance and prognostic stratification than does biopsy","volume":"54","year":"2013","journal-title":"J Nucl Med"},{"key":"bib19-20230925","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1182\/blood-2012-12-473389","article-title":"PET-CT staging of DLBCL accurately identifies and provides new insight into the clinical significance of bone marrow involvement","volume":"122","year":"2013","journal-title":"Blood"},{"key":"bib20-20230925","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s00259-013-2623-4","article-title":"FDG PET\/CT for the detection of bone marrow involvement in diffuse large B-cell lymphoma: systematic review and meta-analysis","volume":"41","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib21-20230925","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/ajh.23730","article-title":"Bone marrow 18F-fluoro-2-deoxy-d-glucose positron emission tomography\/computed tomography cannot replace bone marrow biopsy in diffuse large B-cell lymphoma","volume":"89","year":"2014","journal-title":"Am J Hematol"},{"key":"bib22-20230925","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1093\/annonc\/mdw137","article-title":"The value of routine bone marrow biopsy in patients with diffuse large B-cell lymphoma staged with PET\/CT: a Danish-Canadian study","volume":"27","year":"2016","journal-title":"Ann Oncol"},{"key":"bib23-20230925","doi-asserted-by":"crossref","first-page":"3875","DOI":"10.1182\/blood-2002-09-2778","article-title":"Utility of FDG-PET scanning in lymphoma by WHO classification","volume":"101","year":"2003","journal-title":"Blood"},{"key":"bib24-20230925","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1093\/annonc\/mdm265","article-title":"FDG-PET in T-cell and NK-cell neoplasms","volume":"18","year":"2007","journal-title":"Ann Oncol"},{"key":"bib25-20230925","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s13139-012-0153-9","article-title":"Usefulness of (18)F-FDG PET\/CT for the evaluation of bone marrow involvement in patients with high-grade non-Hodgkin's lymphoma","volume":"46","year":"2012","journal-title":"Nucl Med Mol Imaging"},{"key":"bib26-20230925","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1080\/10428194.2017.1300891","article-title":"Accuracy of 18-F FDG PET\/CT to detect bone marrow clearance in patients with peripheral T-cell lymphoma\u2014tissue remains the issue","volume":"58","year":"2017","journal-title":"Leuk Lymphoma"},{"key":"bib27-20230925","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.clml.2018.06.022","article-title":"Utility of PET-CT for evaluation of patients with peripheral T-cell lymphoma","volume":"18","year":"2018","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"bib28-20230925","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/RLU.0000000000002320","article-title":"FDG PET for evaluation of bone marrow status in T-cell lymphoma","volume":"44","year":"2019","journal-title":"Clin Nucl Med"},{"key":"bib29-20230925","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2307\/2531595","article-title":"Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach","volume":"44","year":"1988","journal-title":"Biometrics"},{"key":"bib31-20230925","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1309\/E5PR-6A9R-Q02N-8QVW","article-title":"Bone marrow involvement by nasal NK cell lymphoma at diagnosis is uncommon","volume":"115","year":"2001","journal-title":"Am J Clin Pathol"},{"key":"bib32-20230925","doi-asserted-by":"crossref","first-page":"3785","DOI":"10.1182\/blood-2005-05-2056","article-title":"Local tumor invasiveness is more predictive of survival than International Prognostic Index in stage I(E)\/II(E) extranodal NK\/T-cell lymphoma, nasal type","volume":"106","year":"2005","journal-title":"Blood"},{"key":"bib33-20230925","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/bjh.14071","article-title":"(18) F-FDG PET-CT and trephine biopsy assessment of bone marrow involvement in lymphoma","volume":"174","year":"2016","journal-title":"Br J Haematol"},{"key":"bib34-20230925","doi-asserted-by":"crossref","first-page":"3402","DOI":"10.1182\/blood-2010-09-310342","article-title":"Peripheral T-cell lymphoma, not otherwise specified: a report of 340 cases from the International Peripheral T-cell Lymphoma Project","volume":"117","year":"2011","journal-title":"Blood"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00003072-201905000-00025","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T06:00:44Z","timestamp":1695621644000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003072-201905000-00025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000002516","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"value":"1536-0229","type":"electronic"},{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]}}}